(Q24244298)

English

Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks

scientific article

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks (English)

0 references

atrial fibrillation

0 references

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

transient cerebral isolation

1 reference

based on heuristic

inferred from title

author name string

Maria I Aguilar

1

author given names

M I

author last names

Aguilar

1 reference

9 December 2023

Robert Hart

2

author given names

R

author last names

Hart

1 reference

9 December 2023

Lesly A Pearce

3

author given names

L A

author last names

Pearce

1 reference

9 December 2023

language of work or name

0 references

publication date

18 July 2007

0 references

Cochrane Database of Systematic Reviews

0 references

3

0 references

CD006186

0 references

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Primary prevention of arterial thromboembolism in the oldest old with atrial fibrillation--a randomized pilot trial comparing adjusted-dose and fixed low-dose coumadin with aspirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Lessons from the Stroke Prevention in Atrial Fibrillation trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Optimal INR for prevention of stroke and death in atrial fibrillation: a critical appraisal

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

21 January 2018

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006186.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24244298&oldid=2026666446"